Fabrice Pierre

1.7k total citations
17 papers, 930 citations indexed

About

Fabrice Pierre is a scholar working on Organic Chemistry, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Fabrice Pierre has authored 17 papers receiving a total of 930 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Organic Chemistry, 10 papers in Molecular Biology and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Fabrice Pierre's work include Synthesis and biological activity (4 papers), Cancer Mechanisms and Therapy (3 papers) and Protein Kinase Regulation and GTPase Signaling (3 papers). Fabrice Pierre is often cited by papers focused on Synthesis and biological activity (4 papers), Cancer Mechanisms and Therapy (3 papers) and Protein Kinase Regulation and GTPase Signaling (3 papers). Fabrice Pierre collaborates with scholars based in France, Italy and Germany. Fabrice Pierre's co-authors include David M. Ryckman, Denis Drygin, Adam Siddiqui-Jain, Sean O’Brien, Kenna Anderes, Mustapha Haddach, William G. Rice, Michael K. Schwaebe, Nicole Streiner and Chris Proffitt and has published in prestigious journals such as Biochemistry, Cancer Research and Chemical Communications.

In The Last Decade

Fabrice Pierre

17 papers receiving 909 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fabrice Pierre France 11 629 254 202 142 67 17 930
Christine Lambert‐van der Brempt United Kingdom 11 520 0.8× 331 1.3× 243 1.2× 50 0.4× 63 0.9× 20 925
Krishna G. Vijayendran United States 5 604 1.0× 195 0.8× 298 1.5× 105 0.7× 38 0.6× 5 847
Martin Pass United Kingdom 16 551 0.9× 212 0.8× 250 1.2× 69 0.5× 62 0.9× 31 873
Nicole Streiner United States 9 1.1k 1.8× 159 0.6× 312 1.5× 114 0.8× 75 1.1× 16 1.4k
Renaud Prudent France 18 687 1.1× 186 0.7× 188 0.9× 62 0.4× 78 1.2× 37 1.1k
Christoph M. Dehnhardt United States 18 641 1.0× 312 1.2× 135 0.7× 103 0.7× 106 1.6× 22 938
Peter Drueckes Switzerland 15 727 1.2× 173 0.7× 290 1.4× 87 0.6× 100 1.5× 24 1.2k
F. Gessier Switzerland 16 559 0.9× 329 1.3× 213 1.1× 58 0.4× 95 1.4× 25 897
John M. Hatcher United States 16 574 0.9× 252 1.0× 211 1.0× 58 0.4× 39 0.6× 33 967
Chris J. Novotny United States 9 642 1.0× 131 0.5× 179 0.9× 81 0.6× 66 1.0× 10 829

Countries citing papers authored by Fabrice Pierre

Since Specialization
Citations

This map shows the geographic impact of Fabrice Pierre's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fabrice Pierre with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fabrice Pierre more than expected).

Fields of papers citing papers by Fabrice Pierre

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fabrice Pierre. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fabrice Pierre. The network helps show where Fabrice Pierre may publish in the future.

Co-authorship network of co-authors of Fabrice Pierre

This figure shows the co-authorship network connecting the top 25 collaborators of Fabrice Pierre. A scholar is included among the top collaborators of Fabrice Pierre based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fabrice Pierre. Fabrice Pierre is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Zhou, Jinglan, et al.. (2014). Synthesis of Fused Bicyclic Piperidines: Potential Bioactive Templates for Medicinal Chemistry. The Journal of Organic Chemistry. 80(1). 70–79. 16 indexed citations
2.
Pierre, Fabrice, Adam Siddiqui-Jain, Nicole Streiner, et al.. (2012). Novel potent dual inhibitors of CK2 and Pim kinases with antiproliferative activity against cancer cells. Bioorganic & Medicinal Chemistry Letters. 22(9). 3327–3331. 28 indexed citations
3.
Pierre, Fabrice, et al.. (2012). A Facile Synthesis of 5-Halopyrimidine-4-Carboxylic Acid Esters via a Minisci Reaction. Synlett. 23(3). 443–447. 5 indexed citations
4.
Haddach, Mustapha, Michael K. Schwaebe, Jerome Michaux, et al.. (2012). Discovery of CX-5461, the First Direct and Selective Inhibitor of RNA Polymerase I, for Cancer Therapeutics. ACS Medicinal Chemistry Letters. 3(7). 602–606. 114 indexed citations
5.
Drygin, Denis, Mustapha Haddach, Fabrice Pierre, & David M. Ryckman. (2012). Potential Use of Selective and Nonselective Pim Kinase Inhibitors for Cancer Therapy. Journal of Medicinal Chemistry. 55(19). 8199–8208. 54 indexed citations
6.
Pierre, Fabrice, Sean O’Brien, Mustapha Haddach, et al.. (2011). Novel potent pyrimido[4,5-c]quinoline inhibitors of protein kinase CK2: SAR and preliminary assessment of their analgesic and anti-viral properties. Bioorganic & Medicinal Chemistry Letters. 21(6). 1687–1691. 28 indexed citations
7.
Pierre, Fabrice, Eric Stefan, Adam Siddiqui-Jain, et al.. (2011). 7-(4H-1,2,4-Triazol-3-yl)benzo[c][2,6]naphthyridines: A novel class of Pim kinase inhibitors with potent cell antiproliferative activity. Bioorganic & Medicinal Chemistry Letters. 21(22). 6687–6692. 46 indexed citations
8.
Haddach, Mustapha, Fabrice Pierre, Jerome Michaux, et al.. (2011). Synthesis and SAR of inhibitors of protein kinase CK2: Novel tricyclic quinoline analogs. Bioorganic & Medicinal Chemistry Letters. 22(1). 45–48. 15 indexed citations
9.
Schwaebe, Michael K., et al.. (2011). Facile and efficient generation of quinolone amides from esters using aluminum chloride. Tetrahedron Letters. 52(10). 1096–1100. 2 indexed citations
10.
Battistutta, Roberto, Giorgio Cozza, Fabrice Pierre, et al.. (2011). Unprecedented Selectivity and Structural Determinants of a New Class of Protein Kinase CK2 Inhibitors in Clinical Trials for the Treatment of Cancer. Biochemistry. 50(39). 8478–8488. 146 indexed citations
11.
Siddiqui-Jain, Adam, Denis Drygin, Nicole Streiner, et al.. (2010). CX-4945, an Orally Bioavailable Selective Inhibitor of Protein Kinase CK2, Inhibits Prosurvival and Angiogenic Signaling and Exhibits Antitumor Efficacy. Cancer Research. 70(24). 10288–10298. 421 indexed citations
12.
Chua, Peter, et al.. (2008). A novel and efficient synthesis of 3-carboxy-4-oxo-1,8-naphthyridines using magnesium chloride. Tetrahedron Letters. 49(28). 4437–4442. 8 indexed citations
13.
Fenêt, Bernard, Fabrice Pierre, Eric Cundliffe, & Marco A. Ciufolini. (2002). The constitution of micrococcin P1: the Bycroft–Gowland hypothesis confirmed. Tetrahedron Letters. 43(13). 2367–2370. 18 indexed citations
14.
Pierre, Fabrice & Dieter Enders. (1999). Nucleophilic alkenoylation of aldehydes with metalated α-aminonitriles: regioselective synthesis of α-hydroxyenones. Tetrahedron Letters. 40(29). 5301–5305. 8 indexed citations
15.
Pierre, Fabrice, Andrea Stricker, Claude Moinet, Sourisak Sinbandhit, & Loı̈c Toupet. (1998). Electrochemical reduction of some [(η5-Cyclopentadienyl) (η6-arene) iron(II)][PF6] complexes bearing an imine or a nitrone function in benzylic position of the arene ligand. Journal of Organometallic Chemistry. 553(1-2). 253–267. 2 indexed citations
16.
Pierre, Fabrice, et al.. (1997). Anodic co-oxidation of urazole and ferrocenes: first trapping of cyclopentadienols. Chemical Communications. 1279–1280. 13 indexed citations
17.
Pierre, Fabrice, Claude Moinet, & Loı̈c Toupet. (1997). Synthesis, structure and hydrolysis of some [(η5-cyclopentadienyl)(η6-arene) iron(II)][PF6] complexes bearing an imine or a nitrone function in α-position of the arene ligand. Journal of Organometallic Chemistry. 527(1-2). 51–64. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christine Lambert‐van der Brempt Breakdown of academic impact, for papers by Krishna G. Vijayendran Breakdown of academic impact, for papers by Martin Pass Breakdown of academic impact, for papers by Nicole Streiner Breakdown of academic impact, for papers by Renaud Prudent Breakdown of academic impact, for papers by Christoph M. Dehnhardt Breakdown of academic impact, for papers by Peter Drueckes Breakdown of academic impact, for papers by F. Gessier Breakdown of academic impact, for papers by John M. Hatcher Breakdown of academic impact, for papers by Chris J. Novotny
Rankless by CCL
2026